期刊文献+

基于树枝状嵌段共聚物的载药微球的制备及其药物释放表征 被引量:2

Preparation and Properties of Microsphere Carriers Based on Biodegradable Comb-Dendritic Tri-Block Copolymers in Controlled Drug Release
下载PDF
导出
摘要 为建立一种树枝状共聚物载药微球的制备方法及其药物释放行为的体外评价机制,研究采用实验室自制的4代树枝状大分子引发剂PEG-G4-(OH)32引发己内酯开环聚合,合成了一系列树枝状三嵌段共聚物,并对其结构进行了表征;采用乳液-溶剂挥发法制备了共聚物-紫杉醇载药微球。研究结果显示,以树枝状嵌段共聚物为壁材的载药微球形貌规整,表面平滑,粒径范围为1.92~2.54μm,载药量为15.7%~20.6%;在0~3d的时间里载药微球释药明显,在随后的3~15d的时间里基本呈现线性的零级释放效果。该研究首次采用树枝化聚己内酯的嵌段共聚物制备载药微球,与以线性聚己内酯为壁材制备的载药微球进行了对比,结果表明,前者药物缓释效果更好,具有一定的临床应用前景。 To develop methods for the preparation of drug loaded microspheres using dendritic copolymers and evaluation of drug release behaviour in vitro, serious of comb-dendritic tri-block copolymers have been synthesized by ring opening polymerization of caprolactone in the presence of a macromolecular initiator PEG-G4-(OH)32. The structures of the copolymers have been characterized. A standard oil-in-water (o/w) emulsion solvent evaporation method was used to fabricate microspheres entrapping paclitaxel using the above copolymers. The obtained microspheres showed smooth surface and spherical size in the range over 1.92-2. 54 μm, and the drug loading content varied from 15. 7% to 20. 6%, depending on the polymer structures. Their paclitaxel release curves were nearly linear,indicating zero-order release kinetics in 3-15 days after an initial relative quick release in the first 3 days. For the first time, this study appllied the dendrintic copolumers to prepare microspheres loading paclitaxel. In comparison with the microspheres prepared from linear PCL, the microspheres using dendritic copolymers showed a better drug releasing profile in the prospect of clinical applications.
出处 《上海交通大学学报(农业科学版)》 2012年第6期6-13,共8页 Journal of Shanghai Jiaotong University(Agricultural Science)
基金 国家自然科学基金(30900495)
关键词 树枝状共聚物 开环聚合 体外释放 载药微球 dendritic copolymers ring opening polymerization release in vitro microspheres loading drug
  • 相关文献

参考文献28

  • 1Zhang W, Shi Y, Chen Y, et al. Multifunctional Plu- ronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resist- ant tumors [J]. Biomaterials, 2011, 32 (11):2894-2906.
  • 2Lopes N M,Adams E G,Pitts T W,et al. Cell kill ki- netics and cell cycle effects of Taxol on human and hamster ovarian cell lines [ J ]. Cancer Chemoth Pharm, 1993,32 (3) : 235-242.
  • 3Zhang Y Q,Tang L,Sun L L,et al. A novel Paclitax- el-loaded PCL/Poloxamer 188 blend nanoparticle o- vercoming multidrug resistance for cancer treatment [J]. Acta Biomater, 2010,6 (6) : 2045-2052.
  • 4Nie H M,Fu Y L,Wang C H. Paclitaxel and suramin- loaded core/shell microspheres in treatment of brain tumors [J~. Biomaterials, 2010,31 (33) : 8732-8740.
  • 5Colin M,Guenard D,Guritte-Voegelein F. Process for preparing derivatives of baccatin Ⅲ and of 10-deacetyl baccatin Ⅲ [P]. US Patent ,No. 4924012,1990.
  • 6Shanmugam S, Parka J H, Chi S C, et al. Antitumor efficacy of solid dispersion of paclitaxel prepared by supercritical antisolvent process in human mammary tumor xenografts [J]. Int J Pharm, 2011,403 (1-2) :130-135.
  • 7Wang T W,Li M J,Gao H X,et al. Nanoparticle car- riers based on copolymers of poly(ε-caprolactone) and hyperbranched polymers for drug delivery [J]. J Colloid Interf Sci, 2011,353 (1) : 107-115.
  • 8Sharma A, Straubinger R M. Novel taxol formula- tions:preparation and characterization of taxol-contai- ning liposomes [J]. Pharrn Res, 1994,11 (6) : 889-896.
  • 9Atanasov V, Sinigersky V, Klapper M, et al. Core? shell macromolecules with rigid dendritic polypheny- lene cores and polymer shells [J]. Maeromoleeules, 2005,38(5) : 1672-1683.
  • 10Gaucher G, Marchessault R H, Leroux J C. Polyester- based micelles and nanoparticles for the parenteral de- livery of taxanes [J]. J Control Release, 2010,143 ( 1): 2-12.

同被引文献45

  • 1王身国,邱波,高家武,段跃新.聚己内酯-聚乙二醇嵌段共聚物Ⅱ.组成、结晶性同降解性间关系[J].高分子学报,1995,5(5):560-565. 被引量:15
  • 2Sparrow J R,Parish C A,Hashimoto M,et al.A2E,a lipofuscin fluorophore,in human retinal pigmented epithelial cells in culture[J].Invest Ophthalmol Vis Sci,1999,40:2988-2994.
  • 3Sparrow J R,Boulton M.RPE lipofuscin and its role in retinal pathobiology[J].Exp Eye Res,2005,80:595-606.
  • 4Iriyama A,Inoue Y,Takahashi H,et al.A2E,a component of lipofuscin,is pro-angiogenic in vivo[J].J Cellular Physiul,2009,220:469-475.
  • 5Marianne Suter,Charlotte Remé,Christian Grimm,et al.The lipofuscin component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells[J].J Biol Chem,2000,275:39625-39630.
  • 6Kurz T,Terman A,Gustafsson B,et al.Lysosomes and oxidative stress in aging and apoptosis[J].Biochim Biophy Acta,2008,1780:1291-1303.
  • 7lee J,Giordano S,Zhang J.Autophagy,mitochondria and oxidative stress:cross-talk and redox signaling[J].Biochem J,2012; 441:523 540.
  • 8Kaarniranta K.Autophagy-hot topic in AMD[J].Acta Ophthulmol,2010,88:387-388.
  • 9Ma L,Lin XM.Effects of lutein and zeaxanthin on aspects of eye health[J].J Sci Food Agric,2010,90:2-12.
  • 10Kalt W,Hanneken A,Milbury P,et al.Recent research on polyphenolics in vision and eye health[J].J Agric Food Chem,2010,58:4001-4007.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部